nivolumab,pembrolizumab,ipilimumab,atezolizumab
merck,bms,roche
['keynote,91', 'nivo', 'check,mate,914', 'rcc,(-irccs),(-srcc),(-urcc)', 'checkmate 914', 'key,note,564', 'pembro']
#esmo22 excellent discussion of on ici in adjuvant setting for rcc - agree with pd1 &gt; pd-l1 - not sure that perioperative design really explain the difference between pembro (keynote-564) and nivo ( prosper)... waiting for checkmate 914 (but only 6 months...) 
urologue à L'institut Paoli-Calmettes à Marseille